Brief: Microba Life Sciences Logs Q4 Total Revenue A$4.07 Million
16/07/2026 02:25
BRIEF-Microba Life Sciences Logs Q4 Total Revenue A$4.07 Million July 16 (Reuters) - Microba Life Sciences Ltd MAP.AX:
Q4 FY26 TOTAL REVENUE A$4.07 MILLION, UP 21% QOQ, DOWN 2% YEAR-ON-YEAR
Further company coverage: MAP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Microba Life Sciences
See all newsBrief: Genetic Signatures Says Microba Shareholders To Hold 60% Of GSS On Merger
Brief: Microba Life Sciences Announces Placement Via Two Tranches
Brief: Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Australia's Genetic Signatures climbs on potential merger with Microba
Brief: Microba Life Sciences Says Microba Signs Multi-Year Synlab Agreement